Epidemiology and risk factors for age related macular degeneration;Épidémiologie et facteurs de risque de la DMLA

Journal Francais d'Ophtalmologie

Volumn 30, Issue HS1, 2007, Pages

  Chaine, G ^a   Rohart, C ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

Ageing; Cardiovascular factors; Incidence; Prevalence; Smoking

Indexed keywords

EID: 34250021133     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol, 1995;39:367-74.
2. BIS. Augwood C, Bentham G, Chakravarthy U, De Jong PTVM, Rahu M, Seland J, et al. Methods for a population-based study of the prevalence of age-related maculopathy and macular degeneration in elderly European populations: the EUREYE study. Ophthalmic Epidemiology, 2004;II:117-29).
3. Klein R, Rowland ML, Harris MI. Racial/ethnic differences in age-related maculopathy: third national health and nutrition examination survey. Ophthalmology, 1995;102:371-81.
4. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph. Surv Ophthalmol, 1980;24:335-61.
5. Bressler NM, Bressler SB, West SK, et al. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol,1989;107:847-52.
6. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology, 1992;99:933.
7. Friedman DS, Katz J, Bressler NM, et al. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. Ophthalmology, 1999;106:1049-55.
8. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology, 1995;102:205-10.
9. Mitchell P, Smith W, Attebo K, et al. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology, 1995;102:1450-60.
10. Schachat AP, Hyman L, Leske C, et al. features of age-related macular degeneration in a black population. Arch. Ophthalmol, 1995;113:728-35.
11. Pagliarim S, Moramarco A, Wormald RPL, et al. Age-related macular disease in rural Southern Italy. Arch Ophthalmol, 1997; 115:616-22.
12. Klein R, Klein BE, Jensen SC, et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology, 1997;104:7-21.
13. Klein R, Klein BE, Tomany SC, et al. Ten-year incidence and progression of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology, 2002;10:1767-79.
14. Mitchell P, Wang JJ, Foran S, et al. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology, 2002;190:1092-7.
15. van Leeuwen R, Klaver CC, Vingerling JR, et al. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam Study. Arch Ophthalmol, 2003;121:519-26.
16. Eye Diseases prevalence research group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol, 2004;122:564-72.
17. Piguet B, Wells JA, Palmvan IB, et al. Age-related Bruch's membrane change: a clinical study of the relative role of heredity and environment. Br J Ophthalmol, 1993;77:400-3.
18. Seddon JM, Samelson U, Page WF, et al. Twin study of macular degeneration: methodology and application to genetic epidemiologic studies. Invest Ophthalmol Vis Sci, 1996;38:676.
19. Seddon JM, De La Paz M, Clements K, et al. No association between apolipoprotein E and advanced age-related macular degeneration. Am J Hum Genet, 1996:559-8.
20. Alikmets R, Singh N, Sun H, et al. A photoreceptor cell-specific Ath-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet, 1997;124:331-43.
21. Baird PN, Guida E, Chu DT, et al. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci, 2004;45:1311-5.
22. Zaperi S, Branham KE, Li M, et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet, 2005; 77:149-53.
23. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science, 2005;308: 385-9.
24. Edwards AO, Ritter R 3rd, Abel KJ, et al. Complement factor H Polymorphism and age-related macular degeneration. Science, 2005;308:421-4.
25. Hains JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science, 2005;308:419-21.
26. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the Age-Related Eye Disease Study: AREDS report no. 3. Ophthalmology, 2000;107:2224-32.
27. Sommer A, Tielsch JM, Katz, et al. Racial differences in the causespecific prevalence of blindness in East Baltimore. N Engl J Med, 1991;325:1412-7.
28. Cruickshanks KJ, Hamman RF, Klein R, et al. The prevalence of age-related maculopathy by geographic region and ethnicity. Arch Ophthalmol, 1997;115:242-50.
29. Wang JJ, Mitchell P, Smith W. Refractive error and age-related maculopathy: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci, 1998;39:2167-71.
30. Holz FG, Piguet B, Minassian DC, et al. Decreasing stromal iris pigmentation as a risk factor for age-related macular degeneration. Am J Ophthtalmol, 1994;117:19-23.
31. Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol, 1992; 110:1701-8.
32. Seddon JM, Hankinson S, Speizer F, et al. A prospective study of smoking and age-related macular degeneration. Am J Epidemiol, 1995;241:136.
33. Seddon JM, Willett WC, Speizer FE et al. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA, 1996;276:1141-6.
34. Age-Related Eye Disease Study Research Group. A randomised, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol, 2001;119:1417-36.
35. Chaine G, Hullo A, Sahel JA, et al. Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group. Br J Ophthalmol, 1998;82:996-1002.
36. Klein R, Klein BE, Tomany SC, et al. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology, 2003; 110:1273-80.
37. Sperduto RD, Hiller R. Systemic hypertension and age-related macular degeneration in the Framingham Eye Study. Arch Ophthalmol, 1986;104:216-26.
38. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol, 1977;106:33-41.
39. Seddon JM, Cho E, Stampfer M, et al. Prospective study of alcohol consumption and the risk of age-related macular degeneration. Invest Ophthalmol Vis Sci, 1999;40:568.
40. Seddon JM, Cote J, Davis N, et al. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol, 2003;21: 785-92.
41. POLA Study Group. Association of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalm Epidemiol, 2001;8:237-49.
42. BIS. Souied EH, Benlian P, Amouyel P, et al. The E4 allele of apolipoprotein gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol, 1998;125: 353-9.
43. van Leeuwen R, Klaver CC, Vingerling JR, et al. Cholesterol and age-related macular degeneration: is there a link? Am J Ophthalmol, 2004;137:750-2.
44. Wilson HL, Schwartz DM, Bhatt HR, et al. Statin ans aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthtalmol, 2004;137:615-24.
45. Snow KK, Cote J, Yang W, et al. Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthtalmol, 2002;134:842-8.
46. van der Hoeve J. Senile Makuladegeneration und senile Lisentrübung. Graefes Arch Ophthalmol, 1918;98:1-6.
47. van der Schaft TL, Mooy CM, de Bruijn WC, et al. Increased prevalence of disciform macular degeneration after cataract extraction with implantation of an intraocular lens. Br J Ophthalmol, 1994;78:441-5.
48. Pollack A, Marcovich A, Bukelman A, et al. Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology, 1996;103:1546-54.
49. Holz FG, Wolfensberger TJ, Piguet B, et al. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology, 1994;101:1522-8.
50. Klein R, Klein BE, Wong TY, et al. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol, 2002;120:1551-8.
51. Wang JJ, Mitchell PG, Cumming RG, et al. Cataract and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol,1999;6:317-26.
52. Klaver CC, Wolfs RC, Vingerling JR, et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol, 1998;116:653-8.